Summary
In this review, some of the current literature on the regulation of proteolysis and angiogenesis during tumor invasion is discussed. Due to the critical location of brain tumors, an understanding of tumor cell interactions with the local environment is particularly relevant. Tissue breakdown during tumor invasion is associated with proteolytic activity, mediated by tumor cells, and surrounding host cells. This review covers two classes of proteinases and inhibitors that have commonly been associated with tumor invasion i.e., plasminogen activator (PA)/plasmin and matrix metalloproteinases (MMP) with special emphasis on the MMP inhibitors, TIMP-1 and TIMP-2. At different steps of the metastatic process, tumor cells interact with endothelial cells. Tumor cells also stimulate the formation of new vessels through the expression of specific angiogenic molecules. At least eight angiogenic molecules have been purified, sequenced and cloned, four of which are discussed here. Regulation of angiogenic activity has been the focus of intense studies recently, and a wide range of synthetic and natural angiogenesis inhibitors have been discovered. Targeting of angiogenic molecules and tumor vasculature may prove useful in future cancer therapeutic strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Heppner GH, Miller BE: Therapeutic implications of tumor heterogeneity. Semin Oncol 16: 91–105, 1989
Shapiro WR, Shapiro JP: Principles of brain tumor chemotherapy. Semin Oncol 13: 56–69, 1987
Cerame MA, Guthikonda M, Kohli CM: Extraneural metastases in gliosarcoma: a case report and review of the literature. Neurosurgery 17: 413–418, 1985
Sherbert GV: The Metastatic Spread of Cancer. MacMillan, London, 1987
Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931–10934, 1992
Brem SS, Zagzag D, Tsanclis AMC, Gately S, Elkouby MP, Brien SE: Inhibition of angiogenesis and tumor growth in the brain. Am J Pathol 136: 1121–1142, 1990
Rutka JT, Apodaca G, Stern R, Rosenblum M: Review article: The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69: 155–170, 1988
Caroni P, Schwab ME: Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 106: 1281–1288, 1988
Bunge RP, Bunge MB: Interrelationship between Schwann cell function and extracellular matrix production. Trends Neurosci 6: 499–505, 1983
Carbonetto S: The extracellular matrix of the nervous system. Trends Neurosci 7: 382–387, 1984
Aquino DA, Margolis RU, Margolis RK: Immunocytochemical localization of a chondroitin sulphate proteoglycan in nervous tissue. I. Adult brain, retina and peripheral nerve. J Cell Biol 99: 1117–1129, 1984
Culp LA, Ansbacher R, Domen C: Adhesion sites of neural tumor cells: biochemical composition. Biochemistry 19: 5899–5907, 1980
McComb RD, Bigner DD: Immunolocalization of laminin in neoplasms of the central and peripheral nervous systems. J Neuropathol Exp Neurol 44: 242–253, 1985
Schiffer D, Giordana MT, Mauro A, Migheli A: GFAP, FVIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study. Acta Neuropathol 63: 108–116, 1984
Flaumenhaft R, Rifkin DB: Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol 3: 817–823, 1991
Paralkar VM, Vukicevic S, Reddi AH: Transforming growth factor β type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Biol 143: 303–308, 1991
Saksela O, Moscatelli D, Sommer A, Rifkin DB: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107: 743–751, 1988
Keski-Oja J, Koli K, Lohi J, Laiho M: Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Semin Tromb Hemost 17: 231–239, 1991
Salonen EM, Saksela O, Vartio T, Vaheri A, Nielsen LS, Zeuthen J: Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem 260: 12302–12307, 1985
Mackay AR, Gomez DE, Cottam DW, Rees RC, Nason AM, Thorgeirsson UP: Identification of the 72 kDa (MMP-2) and 92 kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and matrigelâ„¢. Biotechniques 1993 (in press)
Bar-Shavit R, Eldor A, Vlodavsky I: Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. J Clin Invest 84: 1096–1104, 1989
Mimuro J, Loskutoff DJ: Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that a protein is vitronectin. J Biol Chem 264: 936–939, 1989
Edelberg JM, Reilley CF, Pizzo SV: The inhibition of tissue type plasminogen activator by plasminogen inhibitor-1. The effects of fibrinogen, heparin, vitronectin and lipoprotein (a). J Biol Chem 266: 7488–7493, 1991
Storme G, Mareel M, De Bruyne G: Influence of cell number on directional migration of MO4 cells in vitro. Arch Geschwulstforsch 51: 45–50, 1981
Mullins DE, Rohrlich ST: The role of proteinases in cellular invasiveness. Biochim Biophys Acta 695: 177–214, 1983
Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463–475, 1990
Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD: Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 50: 6039–6044, 1990
Engebraaten O, Bjerkvig R, Pederson P-H, Laerum OD: Effects of EGF, NGF, PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain-tumor biopsies in vitro. Int J Cancer 53: 209–214, 1993
Vassalli JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88: 1067–1072, 1991
Mackay AR, Corbitt RH, Harzler JL, Thorgeirsson UP: Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50: 5997–6001, 1990
Ellis V, Wun TC, Behrendt N, Ronne E, Dano K: Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem 265: 9904–9908, 1990
Blasi F, Behrendt N, Cubellis MV, Ellis V, Lund LR, Masucci MT, Moller LB, Olson DP, Pedersen N, Ploug M, Ronne E, Dano K: The urokinase receptor and regulation of cell surface plasminogen activation. Cell Differ Dev 32: 247–254, 1990
Nusrat AR, Chapman HA: An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest 87: 1091–1097, 1991
Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self regulating system. J Cell Biol 111: 757–763, 1990
Saksela O, Rifkin DB: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activated-mediated proteolytic activity. J Cell Biol 110: 767–775, 1990
Gross JL, Behrens DL, Mullins DE, Kornblith PL, Dexter DL: Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res 48: 291–296, 1988
Festoff BW: Regulation in Development and in Degenerative and Malignant Disease: Serine Proteases and their Serpin Inhibitors in the Nervous System. Plenum Publ Corp, New York, 1990, pp 52–79
Shi GY, Hau JS, Wang SJ, Wu IS, Chang BI, Lin MT, Chow YH, Chang WC, Wing LYC, Jen CJ, Wu HL: Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells. J Biol Chem 267: 19363–19368, 1992
Verrall S, Seeds NW: Characterization of 125I-tissue plasminogen activator binding to cerebellar granule neurons. J Cell Biol 109: 265–271, 1989
Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Ad Cancer Res 44: 139–266, 1985
Pyke C, Graem N, Ralfkier E, Ronne E, Hoyer-Hansen G, Brunner N, Dano K: Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53: 1911–1915, 1993
Dano K, Dabelsteen E, Nielsen LS, Kaltoft K, Wilson EL, Zeuthen J: Plasminogen activating enzyme in cultured glioblastoma cells. J Histochem Cytochem 30: 1165–1170, 1982
Bernstein JJ, Goldberg WJ: Cells from fresh human glioblastoma multiforme migrate into hydrated gels. Proc 84th Meeting American Assoc Cancer Res 1993, p 64
Gloor S, Odink K, Guenther J, Nick H, Monard D: A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47: 687–693, 1986
Guenther J, Nick H, Monard D: A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J 4: 1963–1966, 1985
Knauer DJ, Cunnungham DD: Protease nexins: cell-secreted proteins which regulate extracellular proteases. Trends in Biochem Sci 9: 231–233, 1984
Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN: Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68: 1–19, 1990
Sprengers ED, Kluft C: Plasminogen activator inhibitors. Blood 69: 381–387, 1987
Laiho M, Keski-Oja J: Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 49: 2533–2553, 1989
Farrell DH, Wagner SL, Yuan RH, Cunningham DD: Localization of protease nexin-1 on the fibroblast extracellular matrix. J Cell Physiol 134: 179–188, 1988
Longstaff C, Gaffney PJ: Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. Biochemistry 30: 979–986, 1991
Cottam DW, Rees RC: Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis (Review). Int J Oncol 2: 861–872, 1993
Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121–125, 1990
Halaka AN, Bunning RAN, Gibson M, Reynolds JJ: Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. J Neurosurg 59: 461–466, 1983
Paganetti PA, Caroni P, Schwab ME: Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J Cell Biol 107: 2281–2291, 1988
Apodaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ: Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 50: 2322–2329, 1990
Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R: Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211, 1993
Lund-Johansen M, Rucklidge GJ, Milne G, Bjerkvig R: A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Res 11: 1001–1006, 1991
Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487–498, 1986
Cawston TE: Inhibitors of metalloproteinases. In: Barret AJ, Salveson G (eds) Proteinase Inhibitors. Elsevier, Amsterdam, 1986, pp 589–610
Docherty AJP, Lyon A, Smith BJ, Wright EM, Stephens PE, Harris TJR, Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid potentiating activity. Nature 318: 66–69, 1985
Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83: 2407–2411, 1986
Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He C: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207–8211, 1989
DeClerck YA, Yean TD, Ratzkin BJ, Lu HS, Langley KE: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264: 17445–17453, 1989
Boone TC, Johnson MJ, DeClerck YA, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 87: 2800–2804, 1990
Stetler-Stevenson WG, Brown PD, Omisto M, levy AJ, Liotta LA: Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265: 13933–13938, 1990
Pavloff N, Staskus PW, Kishnani NS, Hawkes S: A new inhibitor of metalloproteinases from chicken: ChIMP-3. J Biol Chem 267:17321–17326, 1992
Jackson IJ, LeCras TD, Docherty AJP: Assignment of the TIMP gene to the murine X-chromosome using an interspecies cross. Nucleic Acids Res 15: 4537, 1987
Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, stricklin GP: Human skin fibroblast collagenase: interaction with substrate and inhibitor. Collagen Relat Res 5:167–179, 1985
Khokha R, Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invas Metas 9: 391–405, 1989
Ganser GL, Stricklin GP, Matrisian LM: EGF and TGFa influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 35: 453–461, 1991
Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899–1904, 1987
Lefebvre V, Peeters Joris C, Vaes G: Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1052: 366–378, 1990
Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinases expression in tumor and normal cell lines. Invas Metas 12:168–184, 1992
Lotz M, Guerne PA: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266: 2017–2020, 1991
Clark SD, Kobayashi DK, Welgus HG: Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 80:1280–1288, 1987
Richards CD, Shoyab M, Brown TJ, Gauldie J: Selective regulation of metalloproteinase inhibitor (TIMP-1) by Oncostatin M in fibroblasts in culture. J Immunol 150: 5596–5603, 1993
Overall CM, Sodek J: Concanavalin A produces a matrixdegradative phenotype in human fibroblasts. J Biol Chem 265: 21141–21151, 1990
Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG: Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 146: 2724–2729, 1991
Ito A, Sato T, Iga T, Mori Y: Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 269: 93–95, 1990
Edwards DR, Waterhouse P, Holman ML, Denhardt DT: A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res 14: 8863–8878, 1986
Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL, Orr EC, Clarck SC: Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315: 768–771, 1985
Bertaux B, Hornebeck W, Eisen AZ, Dubertret L: Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97: 679–685, 1991
Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metal-loproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett 298: 29–32, 1992
Murate T, Yamashita K, Oshashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ, Hayakawa T: Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoie-tin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Exp Hematol 21:169–176, 1993
Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374–17378, 1989
Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, Stetler-Stevenson WG: TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 576: 203–207, 1992
Yang TT, Hawkes SP: Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 89:10676–10680, 1992
Flenniken AM, Williams BRG: Developmental expression of the endogenous TIMP gene and TIMP-lacZ fusion gene in transgenic mice. Genes Dev 4:1094–1106, 1990
Murphy G, Reynolds JJ, Werb Z: Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. J Biol Chem 260: 3079–3083
Hill PA, Reynolds JJ, Meikle MC: Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta 1177: 71–74, 1993
Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118:1271–1282, 1992
Nomura S, Hogan B, Wills AJ, Heath JK, Edwards DR: Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development 105:575–583, 1989
Carmichael DF, Stricklin GP, Stuart JM: Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Agents Actions 27: 378–379, 1989
Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K, Hayakawa T: Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 171:1264–1271, 1990
Moses MA, Sudhalter J, Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408–1410, 1990
Moses MA, Langer R: A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 47: 230–235, 1991
Thorgeirsson UP, Liotta LA, Kalebic T, Margulies IMK, Thomas K, Rios-Candelore M: Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. JNCI 69:1049–1054, 1982
DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE: Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 51: 2151–2157, 1991
Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stet-ler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. JNCI 83: 775–779, 1991
DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708, 1992
Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 53: 1397–1402, 1993
Khokha R, Zimmer MJ, Graham CH, Lala PK, Water-house P: Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. JNCI 84:1017–1022, 1992
Alvarez OA, Carmichael DF, DeClerck YA: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. JNCI 82: 589–595, 1990
Alexander CM, Werb Z: Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J Cell Biol 118: 727–739, 1992
Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT: Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243: 947–950, 1989
Nicolson GL: Tumor and host molecules important in the organ preference of metastasis. Sem Cancer Biol 2: 143–154,1991
McCarthy JB, Skubitz APN, Iida J, Mooradiau DL, Wilke MS, Furcht LT: Tumor cell adhesive mechanisms and their relationship to metastasis. Sem Cancer Biol 2: 155–167, 1991
Rice GE, Bevilacqua MP: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246:1303–1306, 1989
Neugebauer KM, Emmett CJ, Venstrom KA, Reichardt LF: Vitronectin and thrombospondin promote retinal neurite outgrowth: developmental regulation and role of integrins. Neuron 6: 345–358, 1991
Paulus W, Baur I, Schuppan D, Roggendorf W: Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143:154–163, 1993
Wayne Smith C, Anderson DC: PMN adhesion and extravasation as a paradigm for tumor cell dissemination. Cancer Met Rev 10: 61–78, 1991
Kuppner MC, van Meir E, Hamou MF, de Tribolet N: Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clin Exp Immunol 81:142–148, 1990
Fabri Z, Waldschmidt MM, Hendrickson D, Keiner J, Love-Homan L, Takei F, Hart MN: Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55. J Neuroimmunol 36: 1–11, 192
Aruffo A, Dietsch MT, Wan H, Hellstrom KE, Hellstrom I: Granule membrane protein 140 (GMP140) binds to carcinoma-derived cell lines. Proc Natl Acad Sci 89:2292–2296, 1992
Bereta M, Bereta J, Cohen S, Zaifert K, Cohen M: Effect of inflammatory cytokines on the adherence of tumor cells to endothelium in a murine model. Cell Immunol 136: 263–267, 1991
Pober JS: Cytokine-mediated activation of vascular endothelium. Am J Pathol 133: 426–433, 1988
Kelly PJ, Suddith RL, Hutchison HT, Werrbach K, Haber B: Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 44: 342–346, 1976
Paulus W, Peiffer J: Intratumoral histologic heterogeneity of gliomas; a quantitative study. Cancer 64: 442–47, 1989
Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851–858, 1989
Ferrara N, Houk KA, Jakeman LJ, Winer J, Leung DW: The vascular endothelial growth factor family of polypeptides. J Cellular Biochem 47: 211–218, 1992
Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E: Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91: 2235–2243, 1993
Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264: C995–1002, 1993
Jakeman LB, Winer J, Bennett GL, Altar A, Ferrara N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89: 244–253, 1992
Plate KH, Brier G, Weich HA, Risau W: Vascular endothelial cell growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845–848, 1992
Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, van de Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 174:1275–1278, 1991
Berkman RA, Merrill MJ, Reinhold WC, Monnaci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153–159, 1993
Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia mediated angiogenesis. Nature 359: 843–845, 1992
Berse B, Brown LF, van de Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial cell growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 3:211–220, 1992
Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841–844, 1993
Ferrara N, Winer J, Burton T, Rowland A, Siegel M, Phillips HS, Terrell T, Keller GA, Levinson AD: Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest 91:160–170, 1993
Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50: 7393–7398, 1990
Stefanik D, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM: Acidic and basic fibroblast growth factors are present in glioblastoma multiforme and normal brain. Ann NY Acad Sci 638: 477–80,1991
Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM: Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res 51: 5760–5765, 1991
Saxena A, Ali IU: Increased expression of genes from growth factor signalling pathways in glioblastoma cell lines. Oncogene 7: 243–247, 1992
Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D: Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111: 743–755, 1990
Sato Y, Okamura K, Morimoto A, Hamanaka R, Hamaguchi K, Shimada T, Ono M, Kohno K, Sakata T, Kuwano M: Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp Cell Res 204: 223–229, 1993
Lund-Johansen M, Forsberg K, Bjerkvig R, Laerum OD: Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol 84:190–197,1992
Brown PI, Lam R, Lakshmanan J, Fisher DA: Transforming growth factor alpha in developing rats. Am J Physiol 259: E256–260, 1990
Lazar LM, Blum M: Regional distribution and developmental expression of epidermal growth factor and transforming growth factor- mRNA in mouse brain by a quantitative nuclease protection assay. J Neurosci 12:1688–1697, 1992
Baugnet-Mathieu L, Lemaire M, Brotchi J, Levivier M, Born J, Gilles J, Valkenaers-Michaux A, Vangheel V: Epidermal growth factor receptors in human tumors of the central nervous system. Anticancer Res 10:1275–1280, 1990
Yamazaki H, Ahba Y, Tamaoki N, Shibuya M: A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn J Cancer Res 81: 773–779, 1990
Yung WKA, Zhang X, Steck PA, Hung M-C: Differential amplification of the TGF-α gene in human gliomas. Cancer Commun 2: 201–205, 1990
Agosti RM, Leuthold M, Gullick WJ, Yasargil MG, Wiestler OD: Expression of the epidermal growth factor receptor in astrocytic tumors is specifically associated with glioblastoma multiforme. Virchows Archiv A Pathol Anat 420: 321–325, 1992
Ekstrand AJ, James JC, Cavenee WK, Seliger B, Pettersson RF, Collins VP: Genes for epidermal growth factor, transforming growth factor and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164–2172, 1991
Torp SH, Helseth E, Dalen A, Unsgaard G: Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother 33: 61–64, 1991
Dorward NL, Hawkins RA, Whittle IR: Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma. Br J Neurosurg 7:197–200, 1993
Torp SH, Helseth E, Dalen A, Unsgaard G: Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene and prognosis in human glioblastomas. Acta Neurochir (Wien) 117:182–186, 1992
Goldman CK, Kim J, Wong W-L, King V, Brock T, Gillespie GY: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4:121–133, 1993
Heine UI, Munoz EF, Flanders KC, Ellingsworth LR, Lam H-YP, Thompson NL, Roberts AB, Sporn MB: Role of transforming growth factor-β in the development of the mouse embryo. J Cell Biol 105: 2861–2871,1987
Ray Chadhury A, D’Amore PA: Endothelial cell regulation by transforming growth factor-beta. J Cell Biochem 47: 224–229, 1991
Pepper MS, Vassalli J-D, Orci L, Montesano R: Biphasic effect of transforming growth factor-β on in vitro angiogenesis. Exp Cell Res 204: 356–363, 1993
Ueki N, Nakazato M, Ohkawa T, Ikeda T, Amuro Y, Hada T, Higashino K: Excessive production of transforming growth factor-B1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochem Biophys Acta 1137:189–196, 1992
Yang EY, Moses HL: Transforming growth factor-B1 induced changes in cell migration, proliferation and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111: 731–741, 1990
Sutton AB, Canfield AE, Schor SL, Grant ME, Schor AM: The response of endothelial cells to TGF-β is dependent upon cell shape, proliferative state and the nature of the substratum. J Cell Sci 99: 777–787, 1991
Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Garcia M: Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 155: 595–605, 1993
Bodmer S, Strommer K, Frei K, Siepl C, de Tribolet N, Heid I, Fontana A: Immunosuppression and transforming growth factor-β in glioblastoma. J Immunol 143: 3222–3229, 1989
Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A: Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells, astrocytes and microglia. J Immunol 148:1404–1410, 1992
Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldrin C-H: Transforming growth factor-β1, -β2 and -β3 secreted by a human glioblastoma cell line. J Biol Chem 267:19482–19488, 1992
Tada T, Yabu K, Kobayashi S: Detection of active form of transforming growth factor-β in cerebrospinal fluid of patients with glioma. Jpn J Cancer Res 84: 544–548, 1993
Heldin CH, Westermark B: Platelet-derived growth factor and autocrine mechanisms of oncogenic processes. Crit Rev Oncogen 2:109–124, 1991
Reddy UR, Pleasure D: Expression of platelet derived growth factor (PDGF) and PDGF receptor genes in the developing rat brain. J Neurosci Res 31: 670–677, 1992
Pringle NP, Mudhar HS, Collarini EJ, Richardson WD: PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115: 535–551, 1992
Holmgren L, Glaser A, Pfeifer-Ohlsson S, Ohlsson R: Angiogenesis during extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 113: 749–754, 1991
Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Frackelton AR: Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 142: 1119–1130, 1993
Deinhardt F: The biology of primate retrovirus. In: Klein G (ed) Viral Oncology. Raven Press, New York, 1980, pp 359–398
Gazit A, Igarashi H, Chui I-M, Srinivasan A, Yaniv A, Tronick SR, Robbins KC, Aaronson SA: Expression of the normal human c-sis/PDGF-2 coding sequence induces cellular transformation. Cell 39: 89–97, 1984
Mapstone T, McMichael M, Goldthwait D: Expression of platelet-derived growth factors, transforming growth factors and the ras gene in a variety of human brain tumors. Neurosurgery 28: 216–221, 1991
Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU: Amplification and/or over expression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52: 4550–4553, 1992
Hermanson M, Funa K, Hartman M, Claesson-Walsh L, Heldin C-H, Westermark B, Nister M: Platelet-derived growth factor and its receptor in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213–3219, 1992
Plate KH, Breier G, Farrell CL, Risau W: Plateletderived growth factor receptor-β is induced during tumor progression in endothelial cells in human gliomas. Lab Invest 67: 529–534, 1992
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Thorgeirsson, U.P., Lindsay, C.K., Cottam, D.W., Gomez, D.E. (1994). Tumor invasion, proteolysis, and angiogenesis. In: Goldfarb, R.H. (eds) Brain Tumor Invasiveness. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2622-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2622-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6124-4
Online ISBN: 978-1-4615-2622-3
eBook Packages: Springer Book Archive